Intracellular accumulation of thallium as a marker of cisplatin cytotoxicity in nonsmall cell lung carcinoma: An application of inductively coupled plasma mass spectrometry

Cancer

Volumn 83, Issue 5, 1998, Pages 930-935

  Hanada, Taro ^a,c   Isobe, Hiroshi ^b   Saito, Takeshi ^a   Ogura, Shigeaki ^a   Takekawa, Hironori ^a   Yamazaki, Kohichi ^a   Tokuchi, Yoshio ^a   Kawakami, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO CANCER CENTER   (Japan)

^c Tenshi Hospital   (Japan)

Author keywords

Cisplatin accumulation; Inductively coupled plasma mass spectrometry; Na K activated adenosine triphosphatase; Thallium accumulation; Thallium 201 scintigraphy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CISPLATIN; THALLIUM 201;

ANALYTIC METHOD; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DRUG ACCUMULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; MASS SPECTROMETRY; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; THALLIUM RADIOISOTOPES; TUMOR CELLS, CULTURED;

EID: 0032167790     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980901)83:5<930::AID-CNCR19>3.0.CO;2-W     Document Type: Article

References (26)

1. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocardial perfusion. Circulation 1975;51: 641-5.
2. Strauss HW, Boucher CA. Myocardial perfusion studies: lessons from a decade of clinical use. Radiology 1986;160:577-84.
3. Ochi H, Sawa H, Fukuda T, Inoue Y, Nakajima H. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules. Cancer 1982;50:236-40.
4. Tonami N, Shuke N, Yokoyama K, Seki H, Takayama T, Kinuya S, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
5. Matsuno S, Tanabe M, Kawasaki Y, Satoh K, Urrutia AE, Ohkawa M, et al. Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med 1991;19:86-95.
6. +)-activated ATPase of rabbit kidney. Biochim Biophys Acta 1968;159:160-6.
7. Douglas KT, Bunni MA, Baindur SR. Thallium in biochemistry. Int J Biochem 1990;22:429-38.
8. 201Tl uptake in tumours. Eur J Nucl Med 1989;15:376-9.
9. Ohmori T, Nishio K, Ohta S, Kubota N, Adachi M, Komiya K, et al. Ouabain-resistant non-small cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP). Int J Cancer 1994;57:111-6.
10. Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res 1993;53:3302-7.
11. Tokuchi Y, Isobe H, Takekawa H, Hanada T, Ogura S, Itoh H, et al. Predicting chemotherapeutic response to small cell lung cancer of platinum compounds by thallium-201 SPECT. Br J Cancer 1998;77:1363-8.
12. Vanhoe H. A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J Trace Elem Electrolytes Health Dis 1993;7:131-9.
13. Lutz TM, Nivel PMV, Schmidt B. Whole blood analysis by ICP-MS In: Application of plasma source mass spectrometry. Holland H, Eaton AN, editors. Cambridge: Royal Society of Chemistry, 1991:96-100.
14. Lyon TDB, Fell GS. Accuracy of multi-element analysis of human tissue obtained at autopsy using inductively coupled mass spectrometry. J Anal At Spectrom 1991;6:559-64.
15. Sun XF, Ting WTG, Ziesel SH, Janghorbani M. Accurate measurement of stable isotopes of lithium by inductively coupled plasma mass spectrometry. Analyst 1987; 112:1223-8.
16. Kanada T, Isobe H, Saitoh T, Ogura S, Saitoh K, Kawakami Y. Inductively coupled plasma mass spectrometry for the determination of platinum accumulation in human non-small lung cancer cell lines. Int Clin Oncol 1998;3:98-101.
17. Tothill P, Matheson LM, Mckay K, Smyth JF. Inductively coupled plasma mass spectrometry for the determination of platinum in animal tissues and a comparison with atomic absorption spectrometry. J Anal At Spectrom 1990;5:619-22.
18. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Siobhan T, Nofziger TH, et al. Evaluation of a soluble tetrazoliium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-33.
19. Kier AB. Plasma membrane properties of cultured local LM cell tumors and metastases from athymic (nude) mice. Cancer Lett 1990;50:19-30.
20. Takekawa H, Itoh K, Abe S, Ogura S, Isobe H, Sukou N, et al. Retension index of thallium-201 single phonton emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung. Br J Cancer 1994;70: 315-8.
21. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro uptake of Technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with Technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34: 1949-52.
22. Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Ohta S, et al. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/ CDDP). Jpn J Cancer Res 1993;84:83-92.
23. Yoshinaga J. Inductiverly coupled plasma atomic emission spectrometry and ICP mass spectrometry [in Japanese]. Nippon Rinsho 1996;54:202-6.
24. Saddique A, Peterson C. Thallium poisoning: A review. Vet Hum Toxicol 1983;25:16-22.
25. Chandler HA, Scott M. A review of thallium toxicology. J R Nav Med Serv 1986;72:75-9.
26. Andrews PA, Howell SB. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990;2:35-43.